Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
Cancer remains a major global health concern, necessitating the continuous exploration of innovative treatment strategies. This thesis focuses on the development of novel drug delivery systems tailored for targeted cancer therapy. The objective is to enhance the efficacy and reduce the side effects of anticancer drugs through precise delivery to tumor sites. The study begins with an in-depth literature review to establish the current landscape of drug delivery in cancer treatment and identify gaps in existing approaches. Subsequently, a research methodology encompassing the design, formulation, and evaluation of the novel drug delivery systems is implemented. Various parameters such as drug loading capacity, release kinetics, and targeting efficiency are investigated to optimize the performance of the systems. The findings from the experimental work are extensively discussed in Chapter Four, highlighting the key outcomes and implications for targeted cancer therapy. The discussion encompasses the characterization of the developed drug delivery systems, their in vitro and in vivo performance, and comparisons with conventional delivery methods. Insights into the mechanisms of action and potential synergies with existing cancer treatments are also explored. The results underscore the promising potential of the novel drug delivery systems in improving treatment outcomes and reducing adverse effects associated with systemic chemotherapy. In conclusion, this thesis presents a comprehensive overview of the development of novel drug delivery systems for targeted cancer therapy. The study contributes to the growing body of knowledge in the field of pharmaceutical sciences and holds significant promise for advancing precision medicine in oncology. The implications of this research extend beyond academic boundaries, with potential applications in clinical practice to enhance the quality of cancer care. Overall, the thesis underscores the critical role of innovative drug delivery systems in shaping the future of cancer treatment, paving the way for more effective and personalized therapeutic interventions.